Hims & Hers faces lawmaker scrutiny over ‘misleading’ Super Bowl ad
The New York Stock Exchange with a Hims & Hers Health banner is pictured in the Manhattan borough of New…
Health
Read More
Doximity shares pop 30% on revenue beat, rosy guidance
Piotr Swat | Lightrocket | Getty Images Doximity shares ripped more than 30% higher on Friday, a day after the…
Alphabet’s Verily to sell insurance business to Elevance Health
Verily headquarters in San Bruno, California. Courtesy: Verily Verily is selling its stop-loss insurance subsidiary, Granular Insurance Company, to the…
Doximity (DOCS) Q3 earnings 2025
Doximity at the New York Stock Exchange for its initial public offering on June 24, 2021. Source: NYSE Shares of…
Bristol Myers’ stock decline in response to weak guidance is a gift to investors
Bristol Myers Squibb on Thursday reported better-than-expected quarterly results, but weak guidance for 2025 sent shares lower. Jim Cramer’s faith…
Bristol Myers Squibb (BMY) earnings Q4 2024
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman…
Eli Lilly to release weight loss drug retatrutide data in 2025
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14,…
Eli Lilly (LLY) earnings Q4 2024
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Eli Lilly on Thursday…
CEO Lars Fruergaard Jorgensen discusses Wegovy
It’s been a rocky few months for Novo Nordisk. Prescription data from IQVIA suggests Novo’s obesity drug Wegovy is losing…
Senate panel advances RFK Jr.’s nomination to be health secretary
Robert F. Kennedy Jr., U.S. President Trump’s nominee to be secretary of Health and Human Services, testifies before a Senate…